Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

Pharmacophore-Based Virtual Screening: A Comprehensive Workflow Guide for Modern Drug Discovery

This article provides a comprehensive introduction to pharmacophore-based virtual screening (PBVS), a powerful computational method that significantly accelerates drug discovery by identifying potential therapeutic candidates from large chemical databases.

Brooklyn Rose
Nov 29, 2025

Pharmacophore Modeling in Modern Drug Discovery: A Comprehensive Guide to Methods, Applications, and AI-Driven Advances

This article provides a comprehensive examination of pharmacophore modeling's pivotal role in computer-aided drug design, addressing the needs of researchers and drug development professionals.

Jacob Howard
Nov 29, 2025

Pharmacophore Essentials: Mastering the IUPAC Definition and Applications in Drug Discovery

This article provides a comprehensive exploration of the pharmacophore concept, anchored by the official IUPAC definition as 'the ensemble of steric and electronic features' necessary for biological recognition and response.

Christian Bailey
Nov 29, 2025

Target-Specific Scoring Functions: A New Paradigm for Accelerating Cancer Drug Discovery

This article explores the development and optimization of target-specific scoring functions (TSSFs) to overcome the limitations of generic scoring functions in structure-based virtual screening for cancer therapeutics.

Genesis Rose
Nov 29, 2025

Advancing Drug Resistance Prediction: Machine Learning and Genomic Approaches for Improved Accuracy

This article synthesizes current advancements in predicting antimicrobial and antitubercular drug resistance mutations, targeting researchers and drug development professionals.

Aurora Long
Nov 29, 2025

Benchmarking Virtual Screening for Breast Cancer Subtypes: Methods, Challenges, and AI-Driven Advances

This article provides a comprehensive analysis of benchmarking virtual screening (VS) performance across the major molecular subtypes of breast cancer—Luminal, HER2-positive, and Triple-Negative Breast Cancer (TNBC).

Andrew West
Nov 29, 2025

Conquering Tumor Heterogeneity: AI and Multi-Omics Strategies in Computer-Aided Drug Design

Tumor heterogeneity presents a fundamental challenge in oncology drug discovery, often leading to drug resistance and therapeutic failure.

Ava Morgan
Nov 29, 2025

De Novo Drug Design for Oncology: AI-Driven Methods for Novel Cancer Therapeutics

This article provides a comprehensive overview of modern de novo drug design methods and their transformative application in oncology.

Caroline Ward
Nov 29, 2025

Pharmacophore Modeling in Oncology: From Virtual Screening to Clinical Candidates

This article provides a comprehensive overview of pharmacophore modeling applications in oncology drug discovery, tailored for researchers and drug development professionals.

Mason Cooper
Nov 29, 2025

Structure-Based Virtual Screening for HER2-Positive Breast Cancer: From Hit Discovery to Clinical Translation

This article provides a comprehensive overview of structure-based virtual screening (SBVS) applications in developing novel therapeutics for HER2-positive breast cancer.

Levi James
Nov 29, 2025

Popular Articles

Research Tags